Anaplastic large cell lymphoma: A distinct molecular pathologic entity: A reappraisal with special reference to p80(NPM/ALK) expression

American Journal of Surgical Pathology

Volumn 21, Issue 12, 1997, Pages 1420-1432

  Nakamura, Shigeo ^a   Shiota, Mami ^a   Nakagawa, Atsuko ^c   Yatabe, Yasushi ^a   Kojima, Masaru ^d   Motoori, Tadashi ^e   Suzuki, Ritsuro ^a   Kagami, Yoshitoyo ^a   Ogura, Michinori ^a   Morishima, Yasuo ^a   Mizoguchi, Yoshikazu ^f   Okamoto, Masataka ^f   Seto, Masao ^b   Koshikawa, Takashi ^a   Mori, Shigeo ^b   Suchi, Taizan ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d ASHIKAGA RED CROSS HOSPITAL   (Japan)

^e KITASATO INSTITUTE   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ALK; Anaplastic large cell lymphoma; Hodgkin's disease; Hodgkin's like anaplastic large cell lymphoma; Immunohistochemistry; p80

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CD15 ANTIGEN; CD30 ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; GENE PRODUCT; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISOLONE; PROCARBAZINE; PROTEIN BCL 2; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CHILD; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; SKIN LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BONE MARROW; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 0030668343     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199712000-00004     Document Type: Article

References (87)

1. Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988;12:264-74.
2. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1919;74:810-6.
3. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 1993;71:2097-104.
4. Benz-Lemoine E, Brizard A, Huret JL, Babin P, Guilhot F, Couet D, Tanzer J. Malignant histiocytosis: a specific t(2;5) (p23;q35) translocation? Review of the literature. Blood 1988;72:1045-7.
5. Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5) (p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996;149:483-92.
6. Bitter MA, Franklin WA, Larson RA, et al. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5) (p23;q35). Am J Surg Pathol 1990;14:305-16.
7. Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993;23:189-91.
8. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 1994;54:2873-7.
9. Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992;327:1478-84.
10. Cesarman E, Inghirami G, Chadbum A, Knowles DM. High levels of p53 expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 1993;143:845-56.
11. Chan JKC, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol 1990;14:983-8.
12. Chan JKC, Ng CS, Hui PK, Leung TW, Lo ESF, Lau WH, McGuire LJ. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 1989;15:11-34.
13. Chott A, Kaserer K, Augustin I, et al. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 1990;14:439-48.
14. De Bruin PC, Beljaards RC, Van Heerde P, et al. Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null phenotype. Hisopathology 1993;23:127-35.
15. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996;87:3437-41.
16. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992;68:421-7.
17. Downing JR, Shurtleff SA, Zielenska M, et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995;85:3416-22.
18. Ebrahim SAD, Ladanyi M, Desai SB, et al. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes Chromosom Cancer 1990;2:27-35.
19. Elmberger G, Lozano MD, Weisenburger DD, Sanger W, Chan WC. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 1995;86:3517-21.
20. Falini B, Pileri S, Pizzolo G, et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995;85:1-14.
21. Falini B, Pileri S, Stein H, et al. Variable expression of leukocyte common antigen (CD45) in CD30 (Ki-1)-positive anaplastic large-cell lymphoma: implication for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum Pathol 1990;21:624-9.
22. Filippa DA, Ladanyi M, Wollner N, et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic. histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996;87:2905-17.
23. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FGJ, Karpas A. A Ki-1 (CD30)-pogitive human cell line (Karpas 299) established from a high grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 1988;72:234-40.
24. Foss HD, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996;88:4005-11.
25. Fujimoto J, Hata J, Ishii E, et al. 10-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Arch [A] 1988;412:307-14.
26. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 1991;9:539-47.
27. NPM/ALK expression and histology [Abstract]. Blood 1996;88:224.
28. Gruss HJ, Pinto A, Gloghini A, et al. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol 1996;149:469-81.
29. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
30. Herbst H, Anagnostopoutes J, Heinze B, Durkop H, Hummel M, Stein H. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. 1995;86:1694-700.
31. Herbst H, Dallenbich F. Hummel M, et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991;78:2666-73.
32. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
33. Hutchison RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol 1995;13:2023-32.
34. Inghirami O, Marci L, Cesarman E, Chadburn A, Zhong J, Knowles DM. Molecular characterization of CD30+ anapalstic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 1994;83:3581-3590.
35. Kadin ME. Primary Ki-1-positive anaplastie large cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 1994;5(suppl 1):25-30.
36. Kanavaros P, Jiwa NM, De Bruin PC, et al. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas. J Pathol 1992;168:307-15.
37. Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;54) (p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989;73:806-13.
38. + T-cell lymphoma. Am J Surg Pathol 1993;17:859-48.
39. + lymphomas: histiologic and immunophenotypic correlation [Abstract]. Lab Invest 1996;74:114.
40. Kobashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology 1996;28:111-20.
41. Krenacs L, Wellmann A, Sorbara L, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997;89:980-9.
42. Kristoffersson U, Heim S, Heldrup J, Akerman M, Garwitz S, Mitelman F. Cytogenetic studies of childhood non-Hodgkin's lymphomas. Hereditas 1985;103:77-84.
43. Ladanyi M, Cavalchire G. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns. Diagn Mol Pathol 1996;5:154-8.
44. Lamant L, Meggetto F, Al Saati T, et al. High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p80 immunostaining. Blood 1996;87:284-91.
45. Lennert K, Feller AC. Histopathology of Non-Hodgkin's Lymphomas (based on the updated Kiel classification). 2nd ed. Berlin: Springer-Verlag, 1992.
46. Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders. Am J Pathol 1990;137:1047-57.
47. Lopategui JR, Gaffey MJ, Chan JKC, et al. Infrequent association of Epstein-Barr virus with CD30-positive anaplastic large cell lymphomas from American and Asian patients. Am J Surg Pathol 1995;19:42-9.
48. + lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol 1995;146:323-8.
49. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966;26:1063-81.
50. Mason DY, Bastard C, Rimokh R, et al. CD30-positive targe cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990;74:161-8.
51. McKelvey EM, Gottlieb JA, Wilson HE, et al. Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976;38:1484-93.
52. Miettinen M. CD30 distribution: immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and nonHodgkin's lymphomas. Arch Pathol Lab Med 1992;116:1197-201.
53. Morgan R, Hecht BK, Sandberg AA, Hecht F, Smith SD. Chromosome 5q35 breakpoint in malignant histiocytosis. N Engl J Med 1986;314:1322.
54. Morris SW, Kirstein MM, Valentine MB, et al. Fusion of a kinase gene. ALK, to a molecular protein gene. NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-4.
55. NPM/ALK and absence of Epstein-Barr virus. Mod Pathol 1997;10:210-5.
56. Nakamura S, Koshikawa T, Koike K, et al. Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol Jpn 1993;43:396-412.
57. Nakamura S, Sasajima Y, Koshikawa T, et al. Ki-1 (CD30) positive anaplastic large cell lymphoma of T-eell phenotype developing in association with long-standing tuberculous pyothorax: report of a case with detection of Epstein-Barr virus genome in the tumor cells. Hum Pathol 1995;26:1382-5.
58. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 1993;72:1762-72.
59. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96.
60. Nakamura S, Takagi N, Kojima M, et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1 positive targe cell lymphoma) among the Japanese. Cancer 1991;68:118-29.
61. Noorduyn LA, de Bruin PC, van Heerde P, van de Sandt MM, Ossentoppele GJ, Meijer CJLM. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol 1994;47:33-7.
62. Offit K, Ladanyi M, Gangi MD, Ebrahim SAD, Filippa D, Chaganti RSK. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 1990;4:625-30.
63. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive Symphoproliferative disorders of the skin - clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995;13:1343-54.
64. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS. Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer 1991;68:362-73.
65. +): results of a retrospective clinico-pathologic study of 69 cases. Br J 1994;86:513-23.
66. + with a high content of reactive histiocytes). Histopathology 1990;16:383-91.
67. Pileri SA, Piccaluga A, Poggi S, et al. Anaptastic large cell lymphoma: update of findings. Leuk Lymph 1995;18:17-25.
68. Pileri SA, Pulford K, Mori S, et al. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. Am J Pathol 1997;150:1207-11.
69. Pinto A, Aldinucci D, Gloghini A, et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's cell line. Blood 1996;88:3299-305.
70. Piris M, Brown DC, Gatter KC, Mason DY. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990;17:211-8.
71. 69a. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM) - ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997;89:1394-404.
72. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 1989;71:31-6.
73. Shimoyama M, Ota K, Kikuchi M, et al. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol 1988;6:128-41.
74. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S. Hyperphosphorylation of a novel 80 KDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 1994;9:1567-74.
75. Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5) (p23;q35)-associated Ki-l lymphoma with immunohistochemistry. Blood 1994;84:3648-52.
76. NPM/ALK: a distinct clinicopathologic entity. Blood 1995;86:1954-60.
77. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-3.
78. Stein H, Ki-1 anaplastie large cell lymphoma: is it a discrete entity? Leuk Lymph 1993;10(suppl):81-4.
79. Stein H. Hodgkin's disease. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 1997;21:119-20.
80. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-l in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-58.
81. Suchi T, Lennert K, Tu L-Y, Kikuchi M, Sato E, Stansfeld AG, Feller AC. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 1987;40:995-1015.
82. Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formal-resistant epitope. Blood 1989;74:1678-89.
83. Vannier JP, Bastard C, Rossi A, Hemet J, Thomine E, Tron P. Chromosomal t(2;5) and hematological malignancies. Pediatr Hematol Oncol 1987;4:177-8.
84. Weisenburger DD, Gordon BG, Vose JM, et al. Occurrence of the t(2:5) (p23;q35) in non-Hodgkin's lymphoma. Blood. 1996;87:3860-8.
85. + anaplastic large-cell lymphomas, in other non-Hodgkn's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995;86:2321-8.
86. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993;28:973-80.
87. Zinzani PL, Bendandi M, Martelli M, et al. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996;14:955-62.